title: [Ischemic colitis associated with naratriptan administration].
authors.forename: Gilles
authors.initials: G
authors.lastname: Macaigne
authors.forename: Philippe
authors.initials: P
authors.lastname: Simon
authors.forename: Marie-Luce
authors.initials: ML
authors.lastname: Auriault
authors.forename: Jean-François
authors.initials: JF
authors.lastname: Boivin
authors.forename: Eric
authors.initials: E
authors.lastname: Froguel
authors.forename: Claude
authors.initials: C
authors.lastname: Chayette
authors.forename: Sadek
authors.initials: S
authors.lastname: Cheaib
authors.forename: Renaud
authors.initials: R
authors.lastname: Deplus
mesh_terms: D017091:Colitis, Ischemic / Q000139:chemically induced*; D005260:Female; D006801:Humans; D007211:Indoles / Q000009:adverse effects*; D008875:Middle Aged; D008881:Migraine Disorders / Q000188:drug therapy; D010880:Piperidines / Q000009:adverse effects*; D017366:Serotonin Receptor Agonists / Q000009:adverse effects*; D014363:Tryptamines; D014662:Vasoconstrictor Agents / Q000009:adverse effects*
chemical_list: D007211:Indoles; D010880:Piperidines; D017366:Serotonin Receptor Agonists; D014363:Tryptamines; D014662:Vasoconstrictor Agents; C106783:naratriptan